Penumbra, Inc. PEN
Set alert
At close · Oct 30
After hours · Oct 30, 5:36 PM ET
- YTD
- +2.59%
- 1 year
- +37.75%
- Open
- 320.56
- Prev close
- 321.97
- Mkt cap
- 12.57B
- Vol
- 497.16K
- Avg vol
- 346.00K
- EPS
- 3.97
- P/E
- 80.34
- Div yield
- 0.00%
More statistics
- Low
- 318.33
- High
- 321.83
- Forward P/E
- 52.34
- Beta
- 0.70
- Short ratio
- 5.55
- Inst. own
- 88.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 24, 2027
- 50-d avg
- 320.60
- 200-d avg
- 327.46
- 1y target
- 362.54
5Y chart
Events in this range
- Nov 5, 2025Earnings: 0.97; estimate 0.929; surprise 4.41%
- Jan 20, 2026Downgrade: RBC Capital · Outperform → Sector Perform
- Feb 25, 2026Earnings: 1.18; estimate 1.11; surprise 6.31%
- Feb 26, 2026Rating: Evercore ISI Group · Outperform → Outperform
- May 6, 2026Earnings: 0.82; estimate 1.04; surprise -21.15%
- May 7, 2026Rating: Evercore ISI Group · Outperform → Outperform
- May 7, 2026Rating: Citigroup · Neutral → Neutral
- Jun 11, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Jul 6, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Jul 30, 2026Earnings: 0.88; estimate 1.16; surprise -24.14%
- Oct 29, 2026Earnings: 1.07; estimate 1.2; surprise -10.83%
Signals (69)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| MACD: Sell Signal | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| RSI: Overbought | Feb 17, 2025 | 1 year ago |
| RSI: Overbought | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Sep 16, 2024 | 2 years ago |
| SMA: Bearish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | Mar 11, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 11, 2024 | 2 years ago |
| SMA: Bullish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Feb 19, 2024 | 2 years ago |
| SMA: Bearish | Feb 19, 2024 | 2 years ago |
| SMA: Bullish | Jan 22, 2024 | 2 years ago |
| SMA: Bearish | Jan 15, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| SMA: Bullish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Sep 4, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 10, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 10, 2023 | 3 years ago |
| RSI: Overbought | May 29, 2023 | 3 years ago |
| RSI: Overbought | Apr 24, 2023 | 3 years ago |
| RSI: Overbought | Mar 27, 2023 | 3 years ago |
| SMA: Bullish | Mar 13, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| RSI: Overbought | Jan 16, 2023 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Oct 10, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 18, 2022 | 4 years ago |
| RSI: Oversold | Jun 6, 2022 | 4 years ago |
| RSI: Oversold | May 2, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
Key statistics
- Market cap
- 12.57B
- Enterprise value
- 12.24B
- Trailing P/E
- 78.42
- Forward P/E
- 52.34
- PEG ratio
- 3.63
- Price / sales
- 8.35
- Price / book
- 8.77
- EPS (TTM)
- 4.07
- Beta
- 0.70
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 10.67%
- Revenue (TTM)
- 1.50B
- Revenue growth
- 14.90%
- Free cash flow
- 161.10M
- Total cash
- 658.80M
- Total debt
- 212.71M
- Return on equity
- 11.37%
- Shares outstanding
- 39.39M
- Short % of float
- 6.60%
- 50-day average
- 320.60
- 200-day average
- 327.46
Analyst view
Consensus: hold
- Target (low)
- 320.00
- Target (mean)
- 362.54
- Target (high)
- 374.00
- Strong buy1
- Buy2
- Hold14
- Sell0
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 1.48.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 1.44 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.20 | 1.07 | -0.13 | -10.83% |
| Jul 30, 2026 | Jun 30, 2026 | 1.16 | 0.88 | -0.28 | -24.14% |
| May 6, 2026 | Mar 31, 2026 | 1.04 | 0.82 | -0.22 | -21.15% |
| Feb 25, 2026 | Dec 31, 2025 | 1.11 | 1.18 | +0.07 | +6.31% |
| Nov 5, 2025 | Sep 30, 2025 | 0.929 | 0.97 | +0.04 | +4.41% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 6, 2026 | Evercore ISI Group | main | Outperform | Outperform |
| Jun 11, 2026 | RBC Capital | reit | Sector Perform | Sector Perform |
| May 7, 2026 | Citigroup | main | Neutral | Neutral |
| May 7, 2026 | Evercore ISI Group | main | Outperform | Outperform |
| Feb 26, 2026 | Evercore ISI Group | main | Outperform | Outperform |
| Jan 20, 2026 | RBC Capital | down | Outperform | Sector Perform |
About Penumbra, Inc.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- penumbrainc.com
News
- Penumbra Q3 EPS $1.07 Misses $1.25 Estimate, Sales $410.145M Beat $403.345M Estimate
- Penumbra, Inc. Reports Third Quarter 2026 Financial Results
- Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results
- Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
- Penumbra (NYSE:PEN) Stock Breaks Above 50-Day Moving Average – Should You Sell?
- Penumbra Presents Results From Subset Analysis Of STORM-PE Randomized Controlled Trial At Vascular InterVentional Advances Meeting
- New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
- IART vs. PEN: Which Stock Is the Better Value Option?
- Penumbra (NYSE:PEN) Stock Price Breaks Below Fifty Day Moving Average – What’s Next?
- IART or PEN: Which Is the Better Value Stock Right Now?
Your note
Sign in to keep a note on PEN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOSE ARANI | Director | Stock Award(Grant) | Feb 12, 2026 | 259,609 |
| ELSESSER ADAM | Chief Executive Officer | Stock Gift | May 18, 2026 | 0 |
| GREWAL HARPREET SINGH | Director | Sale | Apr 1, 2026 | 8,719 |
| KASSING DON W | Director | Stock Award(Grant) | Feb 13, 2025 | 9,909 |
| LEEDS JANET | Director | Stock Award(Grant) | Feb 12, 2026 | 6,639 |
| NARAYAN SHRUTHI | President | Stock Award(Grant) | Aug 16, 2026 | 33,880 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.91% | 4,297,555 | 1.37B | Jun 29, 2026 |
| HBK Investments L P | 4.67% | 1,838,508 | 586.81M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.34% | 1,709,877 | 545.75M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.23% | 1,667,276 | 532.15M | Jun 29, 2026 |
| State Street Corporation | 3.16% | 1,243,258 | 396.82M | Jun 29, 2026 |
| ExodusPoint Capital Management, LP | 2.77% | 1,090,430 | 348.04M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 1,403,042 | 447.82M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 1,186,100 | 378.57M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.17% | 856,690 | 273.43M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.26% | 494,387 | 157.80M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.14% | 450,774 | 143.88M | Jun 29, 2026 |
| SmallCap World Fund Inc | 1.05% | 412,644 | 131.71M | Sep 29, 2026 |